Synapse - Mark Kris

Results (223)

Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers

Meeting Abstract

Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Novel germline mutations in DNA-damage repair and DNA replication identified in patients with malignant pleural mesothelioma (MPM)

Meeting Abstract

Guo, R.; Duboff, M.; Kris, M.; Ladanyi, M.; Mandelker, D.; Zauderer, M.
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers

Meeting Abstract

Schoenfeld, A. J.; Chan, J. M.; Rizvi, H.; Rekhtman, N.; Daneshbod, Y.; Kubota, D.; Chang, J. C.; Arcila, M. E.; Ladanyi, M.; Somwar, R.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial

Meeting Abstract

Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

MET inhibitor resistance in patients with MET exon 14-altered lung cancers

Meeting Abstract

Guo, R.; Offin, M.; Brannon, A. R.; Chow, A.; Delasos, L.; Somwar, R.; Wilkins, O.; Scott, K.; Tian, Y.; Cecchi, F.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes

Journal Article

Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden

Journal Article

Benayed, R.; Offin, M.; Mullaney, K.; Sukhadia, P.; Rios, K.; Desmeules, P.; Ptashkin, R.; Won, H.; Chang, J.; Halpenny, D.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers

Journal Article

Sabari, J. K.; Offin, M.; Stephens, D.; Ni, A.; Lee, A.; Pavlakis, N.; Clarke, S.; Diakos, C. I.; Datta, S.; Tandon, N.; more...
JNCI: Journal of the National Cancer Institute (2019)

Fulltext@MSK | Save

Immunophenotype and response to immunotherapy of RET-rearranged lung cancers

Journal Article

Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
JCO Precision Oncology (2019)

Fulltext@MSK | Save

Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas

Journal Article

Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
JCO Precision Oncology (2019)

Fulltext@MSK | Save